Kohei Kumegawa

10PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 11, 2026
Colorectal cancer co-opts an epidermal wound healing program during metastasis to generate disseminated tumor cells.

|Dec 27, 2025
Ribosome biogenesis as a potential therapeutic target in KRAS mutant colorectal cancer.

Yui Tanaka, Mizuho Sakahara, Hitomi Yamanaka

|Dec 16, 2025
Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.

Xingxing Wang, Keiko Shinjo, Kohei Kumegawa

|Oct 03, 2024
Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer.

Kazutaka Otsuji, Yoko Takahashi, Tomo Osako

|Mar 01, 2024
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines.

Liying Yang, Kohei Kumegawa, Sumito Saeki

|Jul 13, 2023
TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells.

Hiroshi Kitajima, Reo Maruyama, Takeshi Niinuma

Pageof 2

Frequent Collaborators

8 joint publications

Reo Maruyama

3 joint publications

Tomo Osako

3 joint publications

Takayuki Ueno

2 joint publications

Ryoji Yao